Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
HIV Eradication: One Step Closer
Scientists Crack Integrase Inhibitor Mystery
Gilead Reports Success With Quad Pill and Boosting Drug
New Hope for HIV Eradication
Study: Demand for HIV Vaccine Will Depend on How Good It Is
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

November 26, 2008

Rates of Drug-Resistant Staph Increasing in People With HIV

New cases of skin infections caused by drug-resistant staph have become more common in recent years in some people living with HIV, according to a study published in the November issue of HIV Medicine.

Drug-resistant staph—known as methicillin-resistant Staphylococcus aureus, or MRSA—that is acquired outside a hospital setting has become a growing concern for the general public in the United States in recent years. To determine the impact on HIV-positive patients, Matthew Burkey, MD, from the Johns Hopkins University School of Medicine in Baltimore, and his colleagues examined the medical records of patients being seen at the Johns Hopkins out-patient HIV clinic between January 2000 and December 2004.

Out of 4,607 patients, 216 episodes of staph infection were identified. Of these, 94 cases were MRSA infections. During the four-year period, the incidence of new cases of MRSA more than doubled. Upon further analysis, Dr. Burkey’s team determined that people with end-stage renal disease, CD4 counts below 200 and a history of injection drug use were the most likely to become infected with MRSA.

Search: staph infections, drug resistant, methicillin-resistant Staphylococcus aureus, MRSA, Matthew Burkey, Johns Hopkins University


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 2 (of 2 total)    

kajnjewel, Opelousas, 2008-12-01 03:56:04
For the last two years I have had at three four MRSA infections and the last one put me in the hospital for 1.5 weeks. However, I am not in the later stages of this disease. I have been infected since 1989 and my T's are in the mid 600's. Just wanted to comment and say that MRSA also infects those that are not as progessed in the disease process.

Jason, Edmonton, Alberta, Canada, 2008-11-27 17:16:48
I had two MRSA infections before learning I was positive. My baseline CD4 was 260, suggesting that it may be a risk even with higher CD4 counts.

comments 1 - 2 (of 2 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

17th Conference on Retroviruses and Opportunistic Infections (CROI 2010)
San Francisco, CA
February 16-19, 2010


5th IAS Conference on HIV Pathogenesis Treatment and Prevention (IAS 2009)
Cape Town, South Africa
July 19-22, 2009


16th Conference on Retroviruses and Opportunistic Infections (CROI 2009)
Montréal, Canada
February 8-11, 2009

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2010 Smart + Strong. All Rights Reserved. Terms of use and Your privacy